CBO: Compounding, Track-and-Trace Bills to Pack a Wallop for Industry

The private sector will bear the brunt of costs from combined Senate legislation on track-and-trace and compounding, according to a new federal cost estimate that casts doubt on an already precarious legislative effort.
Washington Drug Letter